Jabra Enhance Select 200 vs Oticon Intent
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.
Choice
Oticon Intent
The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898 and earning an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #4 among 39 prescription hearing aids tested, within the top 8% of its category. In our testing, the Intent demonstrates notable strengths in speech performance, scoring 0.54 points above the category average for speech in quiet and a substantial 0.95 points above average for speech in noise. Music streaming is a particular highlight, measuring 1.24 points above the category average with a strong 4.0/5 score. Feedback handling is excellent at 5.0/5, slightly exceeding the already-high category average. The primary limitation revealed in our testing is own-voice comfort, which scores 1.3/5—a low absolute score that falls 1.40 points below the category average. Users sensitive to the sound of their own voice may find this characteristic noticeable. This is a common trade-off in devices optimized for speech audibility. The Oticon Intent is well-suited for users prioritizing speech understanding across varied listening environments and high-quality audio streaming. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. Shoppers in this premium price tier may also consider the Phonak Sphere Infinio (#2) or the lower-priced Oticon Zeal, which offers strong performance at a reduced cost.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit